L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions

被引:35
作者
Pfeifer, Marco [1 ]
Schirmer, Uwe [1 ]
Geismann, Claudia [2 ]
Schaefer, Heiner [2 ]
Sebens, Susanne [2 ]
Altevogt, Peter [1 ]
机构
[1] German Canc Res Ctr, Dept Translat Immunol, D-69120 Heidelberg, Germany
[2] Univ Kiel, Clin Internal Med 1, Lab Mol Gastroenterol & Hepatol, D-21405 Kiel, Germany
来源
BMC MOLECULAR BIOLOGY | 2010年 / 11卷
关键词
CELL-ADHESION MOLECULE; E-CADHERIN EXPRESSION; BETA-CATENIN; GENE-EXPRESSION; UP-REGULATION; L1; SLUG; GROWTH; CANCER; L1-CAM;
D O I
10.1186/1471-2199-11-64
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The L1 cell adhesion molecule (L1CAM) was originally identified as a neural adhesion molecule involved in axon guidance. In many human epithelial carcinomas L1CAM is overexpressed and thereby augments cell motility, invasion and metastasis formation. L1CAM positive carcinomas are associated with bad prognosis. Recent data point out that L1CAM is regulated in a fashion similar to epithelial- mesenchymal transition (EMT). Previous studies have implied the transcription factors Slug and/or beta-catenin in L1CAM transcriptional regulation. However, the regulation of human L1CAM expression at the transcriptional level is not well understood. Results: To better understand the molecular basis of L1CAM transcriptional regulation, we carried out a detailed characterization of the human L1CAM promoter. We identified two transcription start sites, the first in front of a non-translated exon 0 (promoter 1) and the other next to the first protein-coding exon 1 (promoter 2). Both sites could be verified in endometrial carcinoma (EC) cell lines and appear to be used in a cell-type specific manner. The two identified promoter regions showed activity in luciferase reporter assays. Chromatin-IP analyses confirmed the in silico predicted E-boxes, binding sites for transcription factors Snail and Slug, as well as Lef-1 sites, which are related to beta-catenin-mediated transcriptional regulation, in both promoters. Overexpression of beta-catenin exclusively augmented activity of promoter 1 whereas Slug enhanced promoter 1 and 2 activity suggesting that both promoters can be active. Overexpression of beta-catenin or Slug could upregulate L1CAM expression in a cell-type specific manner. Conclusions: Our results, for the first time, provide evidence that the L1CAM gene has two functionally active promoter sites that are used in a cell-type specific manner. Slug and beta-catenin are involved L1CAM transcriptional regulation. Nevertheless, Slug rather than beta-catenin levels are correlated with L1CAM expression in EC cell lines. Our findings suggest that the L1CAM transcriptional regulation is more complex than anticipated and this study provides the basis for a better understanding of L1CAM regulation in non-neuronal/tumor cells.
引用
收藏
页数:14
相关论文
共 50 条
[21]   L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma [J].
Arciuolo, Damiano ;
Travaglino, Antonio ;
Santoro, Angela ;
Scaglione, Giulia ;
D'Alessandris, Nicoletta ;
Valente, Michele ;
Inzani, Frediano ;
Accarino, Rossella ;
Piermattei, Alessia ;
Benvenuto, Roberta ;
Raffone, Antonio ;
Nero, Camilla ;
Pelligra, Silvia ;
Fanfani, Francesco ;
Mascolo, Massimo ;
Zannoni, Gian Franco .
CANCERS, 2022, 14 (15)
[22]   Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer [J].
Kleppe, Andreas ;
Lindemann, Kristina ;
Kildal, Wanja ;
Tob, Kari Anne R. ;
Pradhan, Manohar ;
Vlatkovic, Ljiljana ;
Isaksen, Maria X. ;
Danielsen, Havard E. ;
Askautrud, Hanne A. ;
Kristensen, Gunnar B. .
GYNECOLOGIC ONCOLOGY, 2025, 192 :80-88
[23]   L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB [J].
Klat, Jaroslav ;
Mladenka, Ales ;
Dvorackova, Jana ;
Bajsova, Sylva ;
Simetka, Ondrej .
ANTICANCER RESEARCH, 2019, 39 (01) :421-424
[24]   L1CAM is an independent predictor Of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA) [J].
Dellinger, Thanh H. ;
Smith, David D. ;
Ouyang, Ching ;
Warden, Charles D. ;
Williams, John C. ;
Han, Ernest S. .
GYNECOLOGIC ONCOLOGY, 2016, 141 (02) :336-340
[25]   L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas [J].
Mancusi de Carvalho, Joao Paulo ;
Salim, Rafael C. ;
Carvalho, Filomena Marino ;
Nogueira Dias Genta, Maria Luiza ;
Baracat, Edmund Chada ;
Carvalho, Jesus Paula .
JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (11) :748-753
[26]   Neuropsin promotes hippocampal synaptogenesis by regulating the expression and cleavage of L1CAM [J].
Barman, Bhabotosh ;
Thakur, Mahendra Kumar .
JOURNAL OF CELL SCIENCE, 2024, 137 (03)
[27]   High L1CAM expression predicts poor prognosis of patients with endometrial cancer A systematic review and meta-analysis [J].
Guo, Min ;
Gong, Han ;
Nie, Dan ;
Li, Zhengyu .
MEDICINE, 2021, 100 (13)
[28]   Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens [J].
Schirmer, Uwe ;
Fiegl, Heidi ;
Pfeifer, Marco ;
Zeimet, Alain G. ;
Mueller-Holzner, Elisabeth ;
Bode, Peter K. ;
Tischler, Verena ;
Altevogt, Peter .
BMC CANCER, 2013, 13
[29]   Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas [J].
Trietsch, Marjolijn D. ;
Oonk, Maaike H. M. ;
Hawinkels, Lukas J. A. C. ;
Bor, Rosalie ;
van Eendenburg, Jaap D. H. ;
Ivanova, Zina ;
Peters, Alexander A. W. ;
Nijman, Hans W. ;
Gaarenstroom, Katja N. ;
Bosse, Tjalling .
ONCOTARGET, 2016, 7 (18) :26192-26205
[30]   L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy [J].
Asano, Hiroshi ;
Hatanaka, Kanako C. ;
Matsuoka, Ryosuke ;
Dong, Peixin ;
Mitamura, Takashi ;
Konno, Yosuke ;
Kato, Tatsuya ;
Kobayashi, Noriko ;
Ihira, Kei ;
Nozaki, Ayako ;
Oku, Akira ;
Matsuno, Yoshihiro ;
Hatanaka, Yutaka ;
Watari, Hidemichi .
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) :2159-2168